Ruedeeporn Tantipolphan

Title: Ruedeeporn Tantipolphan: Innovator in Monoclonal Antibody Formulations

Introduction

Ruedeeporn Tantipolphan is a notable inventor based in Munich, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibody formulations. His work is essential for advancing treatments for specific medical conditions.

Latest Patents

Ruedeeporn holds a patent for a lyophilized formulation of a monoclonal antibody against transthyretin. This invention provides antibody formulations and methods that are useful for the prophylaxis or treatment of transthyretin-related amyloidosis. His innovative approach has the potential to improve patient outcomes significantly.

Career Highlights

Ruedeeporn is currently employed at Novo Nordisk A/S, a leading global healthcare company. His role involves research and development in the field of biopharmaceuticals, where he applies his expertise to create effective therapeutic solutions.

Collaborations

Throughout his career, Ruedeeporn has collaborated with esteemed colleagues, including Joseph Alexander Soto and Andrea Hawe. These partnerships have fostered a collaborative environment that enhances innovation and research in their field.

Conclusion

Ruedeeporn Tantipolphan's contributions to monoclonal antibody formulations exemplify the impact of innovative research in biotechnology. His work not only advances scientific knowledge but also holds promise for improving therapeutic options for patients.